ChemDiv has a long track record as a compound supplier to sophisticated and cost-sensitive, pragmatic users. We serve thousands of customers on six continents; about 200 of them are long-term partners, including all major pharma, biotech and agriculture companies as well as many leading universities.
Largest available >1,500,000 compound collection is synthesized in house at a rate of over 200,000 compounds a year. The compounds are produced using parallel synthesis approaches with yields of 150-250 mg per unit and average purity greater than 90%.
ChemDiv is the partner of choice for screening libraries due to its experience in building a library of drug-like compounds that meet the criteria of the pharmaceutical industry's hit-to-lead discovery process. ChemDiv produces both diverse and focused combinatorial libraries, as well as the proprietary building blocks. We permanently support discovery process of our customers with largest renewable pool of new Templates and Compounds.
If you have an existing therapeutic target but no chemical starting point, we can be your partner to find such a lead.
Chemical arrays between 100-500 members can be prepared or picked up from existing stock around pharmaceutically accepted templates, designed to have a range of drug like and lead like properties. We need 1-2 weeks to generate and propose set of libraries (10-25+) towards customer target or select it immediately from existing stock of 1.5 M compounds.
DISCOVER our unique collections:
Products & Services